Strides Pharma

  • Market Cap: Small Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: INE939A01011
  • NSEID: STAR
  • BSEID: 532531
INR
997.20
26.8 (2.76%)
BSENSE

Aug 06, 03:30 PM

BSE+NSE Vol: 4.38 lacs

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationQuarterly Results
Results Snapshot
YoYQoQ
Figures in Cr
Consolidate Quarterly Results
Jun'26
Mar'26
Dec'25
Sep'25
Jun'25
Mar'25
Dec'24
Net Sales
1,265.41
1,323.47
1,194.65
1,220.83
1,119.74
1,190.39
1,153.67
Other Operating Income
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Total Operating income
1,265.41
1,323.47
1,194.65
1,220.83
1,119.74
1,190.39
1,153.67
Raw Material Cost
414.72
408.88
459.71
429.76
260.58
269.73
476.58
Purchase of Finished goods
166.38
127.45
71.38
41.80
120.91
231.60
133.77
(Increase) / Decrease In Stocks
-85.91
-0.08
-68.14
43.71
62.79
-2.36
-130.23
Employee Cost
242.99
247.11
229.54
226.78
225.52
222.86
215.64
Power Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Manufacturing Expenses
0.00
0.00
-0.01
-0.01
0.00
0.00
0.00
Selling and Distribution Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Expenses
297.45
300.40
266.22
247.23
231.86
250.70
247.60
Total Expenditure (Excl Depreciation)
1,035.63
1,083.76
958.70
989.27
901.66
972.53
943.36
Operating Profit (PBDIT) excl Other Income
229.78
239.71
235.95
231.56
218.08
217.86
210.31
Other Income
4.89
8.13
106.86
27.14
8.58
11.98
5.62
Operating Profit (PBDIT)
234.67
247.84
342.81
258.70
226.66
229.84
215.93
Interest
40.56
41.58
43.38
46.13
47.46
50.32
52.18
Exceptional Items
63.20
-6.41
-3.30
-8.77
-8.37
-27.42
-2.43
Gross Profit (PBDT)
257.31
199.85
296.13
203.80
170.83
152.10
161.32
Depreciation
56.40
53.25
50.62
49.64
48.89
48.86
48.42
Profit Before Tax
199.62
148.05
245.48
153.12
122.04
106.38
113.85
Tax
34.12
18.77
37.35
21.59
16.45
20.76
23.81
Provisions and contingencies
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Profit After Tax
166.78
127.83
208.15
132.57
105.49
82.49
89.09
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Net Profit
166.78
127.83
208.15
132.57
105.49
82.49
89.09
Share in Profit of Associates
-1.29
1.45
-0.03
-1.05
0.10
3.13
0.95
Minority Interest
8.58
2.34
6.02
3.99
5.99
3.42
2.09
Other related items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Consolidated Net Profit
156.91
126.94
202.11
127.53
99.61
82.19
87.95
Equity Capital
92.17
92.17
92.17
92.17
92.16
92.16
92.16
Face Value
10.0
10.0
10.0
10.0
10.0
10.0
10.0
Reserves
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Earnings per share (EPS)
17.02
13.77
21.93
13.84
10.81
8.92
9.54
Diluted Earnings per share
17.02
13.77
21.92
13.84
10.81
8.92
9.55
Operating Profit Margin (Excl OI)
18.16%
18.11%
19.75%
18.97%
19.48%
18.3%
18.23%
Gross Profit Margin
20.33%
15.1%
24.79%
16.69%
15.26%
12.78%
13.98%
PAT Margin
13.08%
9.77%
17.42%
10.77%
9.43%
7.19%
7.8%
Public Share Holdings (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Quarterly Analysis Highlights - YoY
stock-summary

Net Sales

YoY Growth in quarter ended Jun 2026 is 13.01% vs 6.20% in Jun 2025

stock-summary

Consolidate Net Profit

YoY Growth in quarter ended Jun 2026 is 57.52% vs -97.03% in Jun 2025

stock-summary

Operating Profit (PBDIT) excl Other Income

YoY Growth in quarter ended Jun 2026 is 5.37% vs 14.77% in Jun 2025

stock-summary

Interest

YoY Growth in quarter ended Jun 2026 is -14.54% vs -34.56% in Jun 2025

stock-summary

Operating Profit Margin (Excl OI)

YoY Growth in quarter ended Jun 2026 has fallen from Jun 2025

Compare Quarterly Results Of Strides Pharma With
Markets Mojo
Figures in Cr
Consolidate Quarterly Results
Markets Mojo
Markets Mojo
Change(INR)
Change(%)
Net Sales
1,265.41
237.61
1,027.80
432.56%
Other Operating Income
0.00
0.00
0.00
Total Operating income
1,265.41
237.61
1,027.80
432.56%
Raw Material Cost
414.72
120.95
293.77
242.89%
Purchase of Finished goods
166.38
0.48
165.90
34,562.50%
(Increase) / Decrease In Stocks
-85.91
29.93
-115.84
-387.04%
Employee Cost
242.99
20.88
222.11
1,063.75%
Power Cost
0.00
0.00
0.00
Manufacturing Expenses
0.00
0.00
0.00
Selling and Distribution Expenses
0.00
0.00
0.00
Other Expenses
297.45
38.50
258.95
672.60%
Total Expenditure (Excl Depreciation)
1,035.63
210.74
824.89
391.43%
Operating Profit (PBDIT) excl Other Income
229.78
26.87
202.91
755.15%
Other Income
4.89
7.34
-2.45
-33.38%
Operating Profit (PBDIT)
234.67
34.21
200.46
585.97%
Interest
40.56
3.09
37.47
1,212.62%
Exceptional Items
63.20
0.54
62.66
11,603.70%
Gross Profit (PBDT)
257.31
31.66
225.65
712.73%
Depreciation
56.40
8.87
47.53
535.85%
Profit Before Tax
199.62
22.79
176.83
775.91%
Tax
34.12
0.00
34.12
Provisions and contingencies
0.00
0.00
0.00
Profit After Tax
166.78
22.79
143.99
631.81%
Extraordinary Items
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
Net Profit
166.78
22.79
143.99
631.81%
Share in Profit of Associates
-1.29
1.00
-2.29
-229.00%
Minority Interest
8.58
0.00
8.58
Other related items
0.00
0.00
0.00
Consolidated Net Profit
156.91
23.78
133.13
559.84%
Equity Capital
92.17
50.72
41.45
81.72%
Face Value
10.00
10.00
0.00
Reserves
0.00
0.00
0.00
Earnings per share (EPS)
17.02
4.69
12.33
262.90%
Diluted Earnings per share
17.02
4.69
12.33
262.90%
Operating Profit Margin (Excl OI)
18.16%
11.31%
0.00
6.85%
Gross Profit Margin
20.33%
13.32%
0.00
7.01%
PAT Margin
13.08%
9.59%
0.00
3.49%
Public Share Holdings (%)
0.00%
0.00%
0.00
0.00%
Pledged Promotor Holding (%)
0.00%
0.00%
0.00
0.00%
Quarterly - Net Sales
Net Sales 1,265.41 Cr
in Jun 2026

Figures in Cr
stock-summary

QoQ Growth in quarter ended Jun 2026 is -4.39% vs 10.78% in Mar 2026

stock-summary

YoY Growth in quarter ended Jun 2026 is 13.01% vs 6.20% in Jun 2025

Quarterly - Consolidate Net Profit
Consolidate Net Profit 156.91 Cr
in Jun 2026

Figures in Cr
stock-summary

QoQ Growth in quarter ended Jun 2026 is 23.61% vs -37.19% in Mar 2026

stock-summary

YoY Growth in quarter ended Jun 2026 is 57.52% vs -97.03% in Jun 2025

Quarterly - Operating Profit (PBDIT)
Operating Profit (PBDIT) 229.78 Cr
in Jun 2026

Figures in Cr
stock-summary

QoQ Growth in quarter ended Jun 2026 is -4.14% vs 1.59% in Mar 2026

stock-summary

YoY Growth in quarter ended Jun 2026 is 5.37% vs 14.77% in Jun 2025

Quarterly - Interest
Interest 40.56 Cr
in Jun 2026

Figures in Cr
stock-summary

QoQ Growth in quarter ended Jun 2026 is -2.45% vs -4.15% in Mar 2026

stock-summary

YoY Growth in quarter ended Jun 2026 is -14.54% vs -34.56% in Jun 2025

Quarterly - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 18.16%
in Jun 2026

Figures in %
stock-summary

QoQ Growth in quarter ended Jun 2026 has improved from Mar 2026

stock-summary

YoY Growth in quarter ended Jun 2026 has fallen from Jun 2025